Promethazine 25 Mg
$90.00 – $1,600.00
Promethazine 25 Mg | Variation | Price | Price / Unit | Quantity | Add To Cart |
---|---|---|---|---|
30 Tablet/s | $90.00 | $3/ Piece | ||
50 Tablet/s | $137.00 | $2.74/ Piece | ||
100 Tablet/s | $250.00 | $2.5/ Piece | ||
200 Tablet/s | $440.00 | $2.2/ Piece | ||
300 Tablet/s | $600.00 | $2/ Piece | ||
500 Tablet/s | $900.00 | $1.8/ Piece | ||
1000 Tablet/s | $1,600.00 | $1.6/ Piece |
Description
Promethazine is a medication primarily used to treat various allergic reactions, motion sickness, nausea, vomiting, and to help with sedation and sleep. It belongs to the class of antihistamines, which block the effects of histamine, a substance in the body that can cause allergic symptoms. Additionally, promethazine has mild sedative and antiemetic properties, making it useful for managing symptoms such as motion sickness and nausea. It is available in various forms, including tablets, oral solutions, suppositories, and injectable formulations.
Active Ingredient (Generic Name): | Promethazine |
Manufacturer: | Abbott |
Packaging: | 10 Tablets in 1 Strip |
Strength: | 25 MG |
Delivery Time: | 6 To 15 days |
SKU: | Promethazine 25 Mg |
Additional information
Quantity Value | 30 Tablet/s, 50 Tablet/s, 100 Tablet/s, 200 Tablet/s, 300 Tablet/s, 500 Tablet/s, 1000 Tablet/s |
---|
Be the first to review “Promethazine 25 Mg” Cancel reply
You must be logged in to post a review.
Related products
-
Nicorandil 10 mg
0 out of 5$60.00 – $270.00 Select options This product has multiple variants. The options may be chosen on the product page -
Febucip 40 mg (Febuxostat)
0 out of 5$60.00 – $171.00 Select options This product has multiple variants. The options may be chosen on the product page -
Eye Power
0 out of 5$132.00 – $510.00 Select options This product has multiple variants. The options may be chosen on the product page -
Vomikind MD 4 mg
0 out of 5$100.00 – $945.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.